Chronic pulmonary aspergillosis (Q38424): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
A aspergilose pulmonar crônica (APC) apresenta-se como lesão(ões) nodular(es) ou cavitária(s) nos pulmões, com duração de pelo menos três meses. É causada por espécies de Aspergillus, como demonstrado na coloração histológica, por cultura positiva de biópsia ou anticorpos IgG positivos para Aspergillus._x000D_ _x000D_ A forma mais comum de APC é a aspergilose pulmonar cavitária crônica (APCC). Se não for tratada, pode evoluir para aspergilose pulmonar fibrosante crônica (APFC). Manifestações menos comuns de APC incluem nódulo de Aspergillus e aspergiloma único. Todas essas entidades são encontradas em pacientes não imunocomprometidos com doença pulmonar prévia ou atual. A aspergilose pulmonar invasiva subaguda (anteriormente chamada de aspergilose pulmonar necrosante crônica) é uma infecção mais rapidamente progressiva (<3 meses) geralmente encontrada em pacientes moderadamente imunocomprometidos. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Chronic pulmonary aspergillosis (CPA) presents as nodular or cavitary lesion(s) in the lungs, of at least three months duration. It is caused by Aspergillus species as demonstrated on histological staining, by positive culture of biopsy, or positive Aspergillus IgG antibodies. The most common form of CPA is chronic cavitary pulmonary aspergillosis (CCPA). Untreated it may progress to chronic fibrosing pulmonary aspergillosis (CFPA). Less common manifestations of CPA include Aspergillus nodule and single aspergilloma. All these entities are found in non-immunocompromised patients with prior or current lung disease. Subacute invasive pulmonary aspergillosis (formerly called chronic necrotising pulmonary aspergillosis) is a more rapidly progressive infection (<3 months) usually found in moderately immunocompromised patients. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/86747759 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:1F20.12 | |||||||||||||||
| Property / CURIE: CID11:1F20.12 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-1F20.12 | |||||||||||||||
| Property / Canary Token: dki-india-1F20.12 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: B44.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 03:27, 13 August 2026
Chronic pulmonary aspergillosis (CPA) presents as nodular or cavitary lesion(s) in the lungs, of at least three months duration. It is caused by Aspergillus species as demonstrated on histological staining, by positive culture of biopsy, or positive Aspergillus IgG antibodies. The most common form of CPA is chronic cavitary pulmonary aspergillosis (CCPA). Untreated it may progress to chronic fibrosing pulmonary aspergillosis (CFPA). Less common manifestations of CPA include Aspergillus nodule and single aspergilloma. All these entities are found in non-immunocompromised patients with prior or current lung disease. Subacute invasive pulmonary aspergillosis (formerly called chronic necrotising pulmonary aspergillosis) is a more rapidly progressive infection (<3 months) usually found in moderately immunocompromised patients.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 1F20.12 |
||
| English | Chronic pulmonary aspergillosis |
Chronic pulmonary aspergillosis (CPA) presents as nodular or cavitary lesion(s) in the lungs, of at least three months duration. It is caused by Aspergillus species as demonstrated on histological staining, by positive culture of biopsy, or positive Aspergillus IgG antibodies. The most common form of CPA is chronic cavitary pulmonary aspergillosis (CCPA). Untreated it may progress to chronic fibrosing pulmonary aspergillosis (CFPA). Less common manifestations of CPA include Aspergillus nodule and single aspergilloma. All these entities are found in non-immunocompromised patients with prior or current lung disease. Subacute invasive pulmonary aspergillosis (formerly called chronic necrotising pulmonary aspergillosis) is a more rapidly progressive infection (<3 months) usually found in moderately immunocompromised patients. |
Statements
CID11:1F20.12
0 references
dki-india-1F20.12
0 references
Concluído
0 references
13 August 2026
0 references
